Skip to main content

Urinary tract infections in pregnancy in a rural population of Bangladesh: population-based prevalence, risk factors, etiology, and antibiotic resistance



Urinary tract infection (UTI) in pregnancy, including asymptomatic bacteriuria, is associated with maternal morbidity and adverse pregnancy outcomes, including preterm birth and low birthweight. In low-middle income countries (LMICs), the capacity for screening and treatment of UTIs is limited. The objective of this study was to describe the population-based prevalence, risk factors, etiology and antimicrobial resistance patterns of UTIs in pregnancy in Bangladesh.


In a community-based cohort in Sylhet district, Bangladesh, urine specimens were collected at the household level in 4242 pregnant women (< 20 weeks gestation) for culture and antibiotic susceptibility testing. Basic descriptive analysis was performed, as well as logistic regression to calculate adjusted odds ratios (aOR) for UTI risk factors.


The prevalence of UTI was 8.9% (4.4% symptomatic UTI, 4.5% asymptomatic bacteriuria). Risk factors for UTI in this population included maternal undernutrition (mid-upper arm circumference <23 cm: aOR= 1.29, 95% CI: 1.03–1.61), primiparity (aOR= 1.45, 95% CI: 1.15–1.84), and low paternal education (no education: aOR= 1.56, 95% CI: 1.09–2.22). The predominant uro-pathogens were E. coli (38% of isolates), Klebsiella (12%), and staphyloccocal species (23%). Group B streptococcus accounted for 5.3% of uro-pathogens. Rates of antibiotic resistance were high, with only two-thirds of E. coli susceptible to 3rd generation cephalosporins.


In Sylhet, Bangladesh, one in 11 women had a UTI in pregnancy, and approximately half of cases were asymptomatic. There is a need for low-cost and accurate methods for UTI screening in pregnancy and efforts to address increasing rates of antibiotic resistance in LMIC.

Peer Review reports


Urinary tract infections (UTI) in pregnancy are a large and under-emphasized risk factor for pregnancy morbidity and adverse birth outcomes in low- and middle-income country (LMIC) settings [1]. UTI may present in pregnancy with symptoms of acute cystitis or pyelonephritis, or may be more insidious in women with asymptomatic bacteriuria (ASB). Screening and treatment of ASB by urine culture is recommended for all women at least once in early pregnancy in high-income countries, by the Infectious Diseases Society of America [2], Canadian Task Force on Preventive Care [3], and National Institute of Health and Clinical Excellence of the United Kingdom (UK) [4]. In low-income countries, screening and treatment of UTI or ASB is challenging due to the costs and logistics of performing urine culture. Recently, the World Health Organization (WHO) made context-specific antenatal care recommendations for screening and treatment of ASB in LMIC [5], recommending urine culture in settings with capacity, or mid-stream urine Gram stain, and treatment of ASB.

There is a paucity of population-based data on the prevalence and etiology of UTI in pregnancy in low-middle income countries. In a recent review, the global prevalence of UTI and/or ASB in pregnancy ranged from 3 to 35% across 5 continents in countries with preterm birth rates > 10% [1]. Women carry higher risk of UTI than men, and pregnancy places women at increased risk of ascending infection due to the weight of the fetus and dilation of the ureters and renal pelvis [6, 7]. Before urine culture was standard of care in the US (1960’s), pyelonephritis developed in 40% of pregnant women with untreated bacteriuria [8]. Maternal urinary tract infections may trigger an inflammatory response, including the release of chemokines and cytokines that may result in decidual activation, prostaglandin release, and cervical ripening, thereby increasing the risk of preterm birth [9]. In historical studies, approximately 30–50% of women with pyelonephritis delivered preterm [10,11,12]. ASB is significantly associated with preterm delivery (RR 2·00, 95% CI 1·43–2·77) [13], and low birthweight (RR 1.54, 95% CI 1.35–1.75); however, evidence for the impact of ASB screening and treatment on preterm birth risk has been graded as weak [14]. In addition, maternal UTI has been associated with increased risk of stillbirth [15] and early onset neonatal sepsis [16].

We recently screened pregnant women for UTI as part of a cluster-randomized controlled trial ( identifier: NCT01572532) designed to evaluate the impact of a community-based antenatal screening and treatment program for genito-urinary tract infections in early pregnancy on population-level rates of preterm birth in rural Sylhet district, Bangladesh [17, 18]. In this manuscript, we describe the population-based prevalence, risk factors, etiology, and antimicrobial resistance patterns of UTIs in this cohort.


Study population and study design

The data reported in this manuscript were part of a population-based cluster randomized controlled trial (cRCT) to determine the impact of an antenatal screening program for abnormal vaginal flora and UTI on the incidence of preterm live birth ( identifier: NCT01572532) [14, 15]. The study protocol was approved by the institutional review boards of Johns Hopkins Bloomberg School of Public Health Institutional Review Board (Baltimore, Maryland), International Centre for Diarrhoeal Disease Research, Bangladesh Ethical Review Committee (iccdr,b) (Dhaka, Bangladesh), and Partners Human Research Committee (Boston, MA). The Maternal Infection Screening and Treatment (MIST) study [17] was conducted between January 2, 2012 and July 28, 2015 in two rural sub-districts of Sylhet district, Bangladesh: Zakiganj and Khanaighat, which are part of the Projahnmo research site. The study site is in a rural, agrarian area, with poor access to health care and high need, having one of the highest neonatal mortality rates in Bangladesh. Health services in Bangladesh are provided by the government’s Ministry of Health and Family Welfare, NGOs, and private providers. According to the 2014 Bangladesh Demographic and Health Survey, 79% of pregnant women had at least one ANC visit and 31% received at least four ANC visits [19]. Screening for urinary tract infection in pregnancy by urine culture is not standard of care in Bangladesh.

A cluster was defined as the area served by a community health worker (CHW), comprising several contiguous villages (population~ 4000 people, approximately 120 annual pregnancies, per cluster). In MIST, there were 24 clusters, for which community health workers conducted home visits to provide basic antenatal and post-partum care and education. In the cRCT, 12 clusters were randomized to receive the intervention, which included home-based screening and treatment of UTI and abnormal vaginal flora (AVF). In this manuscript, we report the results of the UTI screening. Results of the AVF intervention are reported elsewhere [20].

Pregnancy surveillance

All married women of reproductive age in the study areas were under routine monthly community-based pregnancy surveillance through the duration of the study. Pregnant women who had no or uncertain recall of their last menstrual period (LMP), LMP > 19 weeks, self-reported history of irregular bleeding due to injectable depoprovera, or self-reported history of severe chronic disease were excluded. Participants were enrolled after providing verbal informed consent. Verbal consent was obtained because the majority of the prospective study population was illiterate at the initiation of the study. Documentation of verbal informed consent was formally approved by all institutional review boards.

Urinary tract infection screening

For pregnant women in intervention clusters, during a home visit at < 19 weeks gestation, a clean catch midstream urine specimen was collected for culture. The CHW instructed the mother to spread the labia widely before collecting 20-30 mL of the midstream urine into a sterile wide-mouthed container. The urine specimen was immediately placed in a cooler refrigerated with ice-packs (~ 2 to 8 °C) and transported to the Sylhet field laboratory, maintaining the cold chain. A random selection of 10% of the control arm women also had urine screened by culture.

Laboratory testing

Urine specimens were inoculated on standard MacConkey and Blood agar plates within 6 h of collection and incubated at 37 °C for 48 h. Bacterial growth was quantified twice (24 and 48 h). Bacterial isolates were speciated using standard microbial techniques. Antibiotic susceptibility testing was performed on Mueller-Hinton agar plates following standard laboratory protocols. The disk diffusion method was used; zones of growth inhibition were measured in mm [21]. The antimicrobial discs used were: cefixime, nitrofurantoin, ampicillin, azithromycin, cotrimoxazole, gentamycin, nalidixic acid, ceftriaxone, and cephalexin.


We defined categories of urinary tract infection shown in Table 1. The list of organisms that we considered as UTI pathogens versus contaminants is shown in Additional file 1: Table S1.

Table 1 Clinical Categories of Urinary Tract Infection, Based on Culture Growth and Symptoms

UTI treatment

The MIST treatment algorithm for positive urine cultures is shown in Additional file 1: Figure S1. UTI was treated in pregnant women with high burden growth (> 105 CFU/mL of a uro-pathogen), as well as among women with intermediate growth who had UTI symptoms, as per ACOG recommendations [22]. From January to October 2012, the first line antibiotic treatment was cefixime 400 mg po once daily for 3 days. After observing that only two-thirds of E. coli were susceptible to cefixime, the first-line treatment was then changed to nitrofurantoin (Macrobid) 100 mg po bid for 7 days. All symptomatic women were also referred to the sub-district hospital for further evaluation and management.

A test of cure was obtained 1 week after antibiotic completion for all pregnant women with positive cultures. If the second urine culture remained positive, the supervising field physician prescribed an antibiotic based on the antimicrobial sensitivity pattern. Persistent UTI after twice-repeated treatment was referred to Sylhet Osmani Medical College Hospital for further evaluation and management.

Data analysis

Simple descriptive statistics were used to describe the distribution of uro-pathogens and antibiotic sensitivity patterns.

For the risk factor analysis, the primary outcome was UTI requiring antibiotic treatment, as defined in Table 1. We included a number of socio-demographic characteristics, nutrition, behavior, and reproductive history variables as potential risk factors. Socio-demographic characteristics included household wealth, household size, religion, woman’s age at enrollment, parity, and educational attainment of both the woman and her husband. All variables were categorized. A wealth index indicative of relative economic status of the household within the study population was constructed using household facilities and assets weighted with principal component analysis [23]; the households were categorized into quintiles. Comparisons of proportions between groups were analyzed by chi-squared statistic.

Risk factors with p < 0.05 in bivariate analysis were included in multivariate analysis. Logistic regression was performed to calculate adjusted odds ratios (aORs) and 95% confidence intervals using STATA version 14.0 (StataCorp LP, College Station, TX).


Figure 1 shows a flow chart of patient enrollment and specimens collected as part of the study intervention. The overall rate of urine culture contamination was 4.9% (208/4242). These specimens were excluded from the results reported in Table 2, which report on the first adequate, non-contaminated urine specimens (n = 4034).

Fig. 1

CONSORT Flow Diagram for MIST Study UTI Samples

Table 2 Prevalence of UTI

Prevalence of UTI

In the initial screening of urine samples from the general pregnancy population (n = 4034), 230 (5.7%) women had high burden (> 100,000 CFU/mL) bacteriuria, among which 47 (20.4%) reported clinical signs of UTI, and 183 (79.6%) had no symptoms (Table 2). An additional 599 (14.9%) women in the initial screening had intermediate level (> 1000- < 100,000 CFU/mL) bacteriuria, with 130 (21.7%) of those women reporting UTI symptoms, which were treated with antibiotics. Overall, 360 (8.9%) of women required treatment for UTI, of whom 308 (86%) were started on antibiotics and 284 (92%) completed the full course.

Among women with positive screening urine cultures, we successfully obtained a test of cure specimen in 276/360 women. Among these mothers, 56/276 (20.3%) had a persistent UTI on the second urine culture that required a second course of antibiotics, that was selected based on antimicrobial resistance patterns. Among these women, we obtained a final test of cure specimen from 42 women with persistent UTI. The prevalence of persistent UTI among those women was 26.2% on the final screening.

Risk factors for UTI

Table 3 shows the analysis of risk factors for UTI in this population. In bivariate analysis, low household wealth, primiparity, and maternal undernutrition as measured by MUAC were associated with increased risk of UTI. Higher education of the women and their husbands were protective for UTI. In multivariate analysis (Table 4), low MUAC, low paternal education, and primiparity remained statistically significant risk factors for UTI.

Table 3 Distribution of potential risk factors by UTI status, bivariate analysis
Table 4 UTI Risk Factors, Multivariate Analysis

Etiology of UTI

Figure 2 shows the bacterial etiology of UTI pathogens among pregnant mothers who were treated (high burden and intermediate growth in symptomatic mothers; n = 360) in the initial screening of the general pregnancy population in Sylhet, Bangladesh. The predominant micro-organisms were E. coli (n = 135; 38% of isolates) and Staphylococcus species (non-aureus) (n = 82; 23%), followed by Klebsiella species (n = 44, 12%). Staphylococcus aureus was common, isolated in 42 (12%) women with UTI. The prevalence of Group B Streptococcus (GBS) bacteriuria was generally lower, with 19 isolates (n = 19; 5.3%).

Fig. 2

UTI Pathogens in First Adequate Urine Screening

Among the intermediate growth in mothers who were asymptomatic, there was a predominance of skin contaminants, including staph and strep species, and these are shown in the Additional file 1: Figure S2.

Antimicrobial susceptibility patterns

Table 5 shows the antimicrobial susceptibility patterns of uro-pathogens in the MIST study. E. coli isolates had low rates of susceptibility to ampicillin (34% of isolates) and azithromycin (28%); susceptibility to cefixime, cotrimoxazole, and cephalexin were in the moderate range (69, 63, and 62% respectively). The majority of species were highly susceptible to nitrofurantoin, with the exception of Klebsiella species, where 74% of strains were susceptible. Rates of susceptibility to azithromycin were low among the gram-negative species.

Table 5 Antibiotic Susceptibility Patterns of Uropathogens in the MIST Study


In a cohort of pregnant women in rural Sylhet, Bangladesh, the prevalence of UTI in early pregnancy was 8.9% (4.4% symptomatic UTI, 4.5% asymptomatic bacteriuria). A majority of women with bacteriuria in pregnancy were asymptomatic. Risk factors for UTI in this population included maternal undernutrition, primiparity, and low paternal education. The common uro-pathogens were similar to those reported in other geographies, with a predominance of gram negatives, including E. coli and Klebsiella, as well as staphyloccocal species. Group B streptococcus accounted for only 5.3% of uro-pathogens. Rates of antibiotic resistance were high, with greater than 30% of E. coli resistant to 3rd generation cephalosporins.

The prevalence of UTI/ASB in our study population was comparable to other studies in South Asia. In our study, we sampled all pregnant women identified from households in the study catchment area. This differs from the majority of studies, which recruited pregnant women presenting at ANC clinics or tertiary care facilities. One Bangladeshi study recruiting from ANC clinics reported a 5% bacteriuria rate, with 1% of women presenting with UTI symptoms [24]. Reports from urban and rural Rajshahi district, Bangladesh reported that 4–12% of women presenting to antenatal care had asymptomatic bacteriuria [25, 26]. In a study of mothers at an ANC clinic in rural Nagpur, India the culture-positive UTI (symptomatic and asymptomatic) prevalence was 9.6%, similar to our study [27]. Two studies in urban settings in northern India reported higher prevalence of ASB and UTI, ranging from 19.9% ASB prevalence in primary care clinics [28] to 25.5% prevalence of symptomatic UTI in a tertiary care ANC clinic in Lucknow [29].

In our pregnancy cohort, the majority of women with bacteriuria in were asymptomatic. This has relevance with respect to screening procedures in LMIC. A symptomatic approach to UTI will miss the majority of cases and the opportunity for intervention-treatment to prevent maternal morbidity and adverse pregnancy outcomes. While urine culture is standard of care in high income countries (HIC), it is typically costly and requires laboratory resources, infrastructure, and personnel and is not feasible in many LMIC settings. The diagnostic accuracy of urine dipstick and gram stain for diagnosis of ASB is poor, with particularly low sensitivity [30, 31]. Lower cost, feasible, and accurate point of care methods/diagnostics for screening for ASB are urgently needed to improve detection and management of UTI in LMIC.

Primiparity, less paternal education, and maternal undernutrition were significant risk factors for UTI in this population. Poor hygiene practices may be more common in first time mothers of young age and those with low SES, and predispose them to urinary tract infection [32]. Low paternal education is a marker for low SES, a frequently reported risk factor for UTI [32]. Maternal undernutrition, defined as maternal MUAC < 23 cm, was also observed to be a risk factor for UTI in this population. Malnutrition is an important and under-recognized cause of immunodeficiency globally [33]. Protein energy malnutrition may impair immune function (i.e. antigen-presenting cell and cell mediated T-cell function), and increase risk of maternal infections, including UTI [34,35,36]. Undernutrition has been identified as a risk for UTI in children [37] and the elderly [38]. However, to our knowledge, this is the first report of this association between maternal undernutrition and UTI in a pregnancy population in a LMIC.

Gram-negative organisms, E. coli and Klebsiella species, were common etiologies of UTI in Sylhet, accounting for half (38 and 12%, respectively) of cases of significant bacteriuria. Other studies of UTI etiology in Bangladesh have similarly reported a predominance of gram negatives, particularly E. coli, which comprised 59–75% of isolates, and Klebsiella species, which ranged from 6 to 11% of isolates [39, 40]. In a 5-year, large, prospective study of pregnant women in a tertiary care hospital in India, E. coli and Klebsiella pneumoniae were the most common uro-pathogens (42 and 22% of isolates, respectively) [41].

In this population, there was also a high rate of isolation of gram-positive organisms. Specifically, staphylococcal species (non-aureus) were the second most common uro-pathogen overall, contributing to 23% of positive cultures. The majority of these isolates were presumably Staphylococcus saprophyticus, a leading cause of cystitis in young women [42]. However, our field laboratory did not have the capacity to further speciate with novobiocin resistance testing. Other studies in Bangladesh have reported that S. saprophyticus [43] comprised 11–19% of uro-pathogens [39, 44]. In India, S. saprophyticus comprised 10.6% of positive cultures [45]. While S. aureus is often considered skin flora, it accounted for 12% of cases of UTI in Sylhet. While precautions were taken to avoid skin contamination, it is difficult to ascertain whether the bacteriuria was due to skin contamination or whether it was a true uro-pathogen [1]. Among cases of S. aureus bacteriuria, approximately 82% were asymptomatic. S. aureus was described as an emerging etiology of UTI in LMIC in a recent global burden review [1]. In Nigeria, S. aureus comprised approximately 24 to 28% of isolates in women with bacteriuria or clinical UTI [46, 47]. A study of pregnancy-associated ASB in Sudan reported that S. aureus comprised 39% of cases [48]. A lower contribution of S. aureus infection was reported in India (5.9%) [41].

Antibiotic resistance is a growing concern, particularly in LMIC, and our study demonstrates high and concerning rates of antibiotic resistance to common antimicrobial agents for treatment of UTI in pregnancy. The gram-negative uro-pathogens were highly resistant to ampicillin and azithromycin. More than 30% of E. coli isolates were not susceptible to common 2nd and 3rd generation cephalosporins. Among the most common uro-pathogens, E. coli and staphylococcal species, there was only low-to- moderate susceptibility to cefixime, a traditionally potent oral 3rd generation cephalosporin. Similar high and concerning rates of antibiotic resistance were reported in the WHO Global Surveillance of Antimicrobials. In national level data from South-East Asia, 16–68% of E. coli isolates, and 34–81% of Klebsiella isolates were resistant to 3rd generation cephalosporins [49, 50]. This data emphasizes the urgency for antibiotic stewardship in LMIC, and the need to also develop new effective antimicrobials with safety in pregnancy.

There were several limitations to this study. We did not have the ability to speciate coagulase-negative staphylococcal species in our field laboratory. We presume the majority of these species were Staphylococcus saprophyticus, however, it is possible that some of these may have been Staphylococcus epidermidis, which might be considered a skin contaminant. Another challenge is the differentiation of skin contamination vs. true pathogens. The rates of S. aureus growth were high, and it is difficult, if not impossible, to determine what proportion of those should be considered as UTI pathogens, particularly in asymptomatic women. While we used clean catch midstream urine specimens, the samples were collected in homes, and it is possible that some were skin contaminants. We also did not systematically collect cost data, which would have been useful to determine the cost-effectiveness of our program. There is a paucity of evidence on the cost-effectiveness of screening-treatment programs for UTI in pregnancy, which is of particular relevance in LMICs. Finally, we did not have extensive data on several known behavioral risk factors for UTI, including sexual history or toileting practices.


The screening and treatment of urinary tract infections in pregnancy is standard of care in high-income countries and is now recommended by the WHO for LMIC. In rural Sylhet, Bangladesh, an estimated one in 11 pregnant women in the general population had a UTI that required antibiotic treatment. The majority of women with bacteriuria had no symptoms. Low paternal education, primparity, and maternal undernutrition were important risk factors for UTI. Rates of antibiotic resistance were concerningly high, particularly in E. coli strains. Further research is needed to identify low-cost, feasible, and accurate methods for UTI screening and to address high rates of antibiotic resistance in LMIC.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Antenatal care


Asymptomatic bacteriuria


Atypical vaginal flora


Community health worker


Low- and middle-income countries


Last menstrual period


Maternal infection screening and treatment (study)


Mid-upper arm circumference


Urinary tract infection


World Health Organization


  1. 1.

    Gilbert NM, O'Brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Glob Adv Health Med. 2013;2(5):59–69.

    PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, et al. Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643–54.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Nicolle LE. Screening for asymptomatic bacteriuria in pregnancy Canadian guide to clinical preventative care. Health Canada: Ottowa; 1994.

    Google Scholar 

  4. 4.

    National Collaborating Center for Women’s and Children’s Health Antenatal care: routine care for the healthy pregnant woman. London: RCOG Press; 2008.

  5. 5.

    World Health Organization (WHO). WHO recommendations on antental care for a positive pregnancy experience. Geneva: 2016.

  6. 6.

    Gebre-Selassie S. Asymptomatic bacteriuria in pregnancy: epidemiological, clinical and microbiological approach. Ethiop Med J. 1998;36(3):185–92.

    CAS  PubMed  Google Scholar 

  7. 7.

    Akerele J, Abhulimen P, Okonofua F. Prevalence of asymptomatic bacteriuria among pregnant women in Benin City, Nigeria. J Obstet Gynaecol. 2001;21(2):141–4.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Whalley P. Bacteriuria of pregnancy. Am J Obstet Gynecol. 1967;97(5):723–38.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev. 2007;65(12 Pt 2):S194–202.

    PubMed  Article  Google Scholar 

  10. 10.

    Hill JBSJ, McIntire DD, Wendel GD Jr. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105:18–23.

    PubMed  Article  PubMed Central  Google Scholar 

  11. 11.

    Kass EH. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med. 1960;105:194–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Kass EH. Pyelonephritis and bacteriuria. A major problem in preventive medicine. Ann Intern Med. 1962;56:46–53.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 1989;73(4):576–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Barros FCBZ, Batra M, Hansen TN, Victora CG, Rubens CE. GAPPS Review Group. Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions. BMC Pregnancy Childbirth. 2010;10(Suppl 1):S3.

    PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    McClure EM, Goldenberg RL. Infection and stillbirth. Semin Fetal Neonatal Med. 2009;14(4):182–89.

    PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med. 2013;10(8):e1001502.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Lee AC, Quaiyum MA, Mullany LC, Mitra DK, Labrique A, Ahmed P, et al. Screening and treatment of maternal genitourinary tract infections in early pregnancy to prevent preterm birth in rural Sylhet, Bangladesh: a cluster randomized trial. BMC Pregnancy Childbirth. 2015;15:326.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  18. 18.

    Lee AC, Mullany LC, Quaiyum M, Mitra DK, Labrique A, Christian P, et al. Effect of population-based antenatal screening and treatment of genitourinary tract infections on birth outcomes in Sylhet, Bangladesh (MIST): a cluster-randomised clinical trial. Lancet Glob Health. 2019;7(1):e148–e59.

    PubMed  Article  PubMed Central  Google Scholar 

  19. 19.

    Bangladesh Demographic and Health Survey 2014. Dhaka, Bangladesh and Rockville, Maryland: National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International; 2016.

  20. 20.

    Baqui AH, Lee ACC, Koffi AK, Khanam R, Mitra DK, Dasgupta SK, et al. Prevalence of and risk factors for abnormal vaginal flora and its association with adverse pregnancy outcomes in a rural district in north-East Bangladesh. Acta Obstet Gynecol Scand. 2019;98(3):309–19.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci. 2012;4(4):163–9.

    PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    ACOG Practice Bulletin No. 91: treatment of urinary tract infections in nonpregnant women. Obstet Gynecol 2008;111(3):785–794.

  23. 23.

    Filmer D, Pritchett LH. Estimating wealth effects without expenditure data--or tears: an application to educational enrollments in states of India. Demography. 2001;38(1):115–32.

    CAS  PubMed  Google Scholar 

  24. 24.

    Razzaque SM, Rahman KM. Bacteriuria and urinary tract infection in pregnancy. Bangladesh Med Res Counc Bull. 1977;3(2):145–8.

    CAS  PubMed  Google Scholar 

  25. 25.

    Ullah A, Barman A, Ahmed I, Salam A. Asymptomatic bacteriuria in pregnant mothers: a valid and cost-effective screening test in Bangladesh. J Obstet Gynaecol. 2012;32(1):37–41.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Ullah MA, Barman A, Siddique MA, Haque AK. Prevalence of asymptomatic bacteriuria and its consequences in pregnancy in a rural community of Bangladesh. Bangladesh Med Res Counc Bull. 2007;33(2):60–4.

    PubMed  Article  Google Scholar 

  27. 27.

    Thakre SS, Dhakne SS, Thakre SB, Thakre AD, Ughade SM, Kale P. Can the Griess nitrite test and a urinary pus cell count of >/=5 cells per micro litre of urine in pregnant women be used for the screening or the early detection of urinary tract infections in rural India? J Clin Diagn Res. 2012;6(9):1518–22.

    PubMed  PubMed Central  Google Scholar 

  28. 28.

    Bandyopadhyay S, Thakur JS, Ray P, Kumar R. High prevalence of bacteriuria in pregnancy and its screening methods in North India. J Indian Med Assoc. 2005;103(5):259–62 66.

    PubMed  Google Scholar 

  29. 29.

    Lata I, Pradeep Y, Sujata JA. Estimation of the incidence of bacterial Vaginosis and other vaginal infections and its consequences on maternal/fetal outcome in pregnant women attending an antenatal Clinic in a Tertiary Care Hospital in North India. Indian J Community Med. 2010;35(2):285–9.

    PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Rogozinska E, Formina S, Zamora J, Mignini L, Khan KS. Accuracy of onsite tests to detect asymptomatic Bacteriuria in pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2016;128(3):495–503.

    PubMed  Article  Google Scholar 

  31. 31.

    Ajayi AB, Nwabuisi C, Aboyeji PO, Fowotade A, Fakeye OO. Reliability of urine multistix and gram stain in the detection of asymptomatic bacteriuria in pregnancy. West Afr J Med. 2010;29(5):339–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Investig. 2008;38(Suppl 2):50–7.

    Article  Google Scholar 

  33. 33.

    Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46(10):1582–8.

    PubMed  Article  PubMed Central  Google Scholar 

  34. 34.

    Raiten DJ, Sakr Ashour FA, Ross AC, Meydani SN, Dawson HD, Stephensen CB, et al. Inflammation and nutritional science for programs/policies and interpretation of research evidence (INSPIRE). J Nutr. 2015;145(5):1039S–108S.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Ahmad SM, Haskell MJ, Raqib R, Stephensen CB. Vitamin a status is associated with T-cell responses in Bangladeshi men. Br J Nutr. 2009;102(6):797–802.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Hughes SM, Amadi B, Mwiya M, Nkamba H, Tomkins A, Goldblatt D. Dendritic cell anergy results from endotoxemia in severe malnutrition. J Immunol. 2009;183(4):2818–26.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Bagga A, Tripathi P, Jatana V, Hari P, Kapil A, Srivastava RN, et al. Bacteriuria and urinary tract infections in malnourished children. Pediatric Nephrol. 2003;18(4):366–70.

    Article  Google Scholar 

  38. 38.

    Carlsson M, Haglin L, Rosendahl E, Gustafson Y. Poor nutritional status is associated with urinary tract infection among older people living in residential care facilities. J Nutr Health Aging. 2013;17(2):186–91.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    Haque R, Akter ML, Salam MA. Prevalence and susceptibility of uropathogens: a recent report from a teaching hospital in Bangladesh. BMC Res Notes. 2015;8:416.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  40. 40.

    Majumder MI, Ahmed T, Hossain D, Begum SA. Bacteriology and antibiotic sensitivity patterns of urinary tract infections in a tertiary hospital in Bangladesh. Mymensingh Med J. 2014;23(1):99–104.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Rizvi M, Khan F, Shukla I, Malik A. Shaheen. Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options. J Lab Physicians. 2011;3(2):98–103.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Raz R, Colodner R, Kunin CM. Who are you--Staphylococcus saprophyticus? Clin Infect Dis. 2005;40(6):896–8.

    PubMed  Article  Google Scholar 

  43. 43.

    Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014;27(4):870–926.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Parvin US, Hossain MA, Musa AK, Mahamud C, Islam MT, Haque N, et al. Pattern of aerobic bacteria with antimicrobial susceptibility causing community acquired urinary tract infection. Mymensingh Med J. 2009;18(2):148–53.

    CAS  PubMed  Google Scholar 

  45. 45.

    Jayalakshmi J, Jayaram VS. Evaluation of various screening tests to detect asymptomatic bacteriuria in pregnant women. Indian J Pathol Microbiol. 2008;51(3):379–81.

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Imade PE, Izekor PE, Eghafona NO, Enabulele OI, Ophori E. Asymptomatic bacteriuria among pregnant women. N Am J Med Sci. 2010;2(6):263–6.

    PubMed  PubMed Central  Google Scholar 

  47. 47.

    Oli AN, Akabueze VB, Ezeudu CE, Eleje GU, Ejiofor OS, Ezebialu IU, et al. Bacteriology and Antibiogram of urinary tract infection among female patients in a tertiary health Facility in South Eastern Nigeria. Open Microbiol J. 2017;11:292–300.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Hamdan HZ, Ziad AH, Ali SK, Adam I. Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum north hospital. Ann Clin Microbiol Antimicrob. 2011;10:2.

    PubMed  PubMed Central  Article  Google Scholar 

  49. 49.

    Antimicrobial Resistance Global Report on Surveillance. Geneva, Switzerland: World Health Organization (WHO); 2014.

  50. 50.

    The world is running out of antibiotics, WHO report confirms [press release]. 2017.

Download references


We would like to acknowledge the dedicated Projahnmo MIST team involved the design, conduct and implementation of this trial–management team (Rashed Shah), medical officers (Monir Zaman, Salaheen Towhid), project officers (Ashraf Eusufzi, Sadia Naznin), field supervisory staff (Ataur Rahim), laboratory team (Maksuda Islam, Roman Mortuza, Robel Partaway, Tarik Hassan, Mashuk Siddiquee, Zabed Ahmed), community health workers and village health workers. We would also like to thank Ingrid Olson for her assistance formatting the manuscript for submission. Finally, we would like to thank the mothers and infants who participated in this trial.


This work was funded by a grant from the NICHD (R01 HD066156–02). The funding body played no role in the design of the study; the collection, analysis, or interpretation of data; nor in the writing the manuscript.

Author information




AHB, ACL, LCM, PC, AL, MQ, SS conceived and designed the study. AHB, ACL, LCM, IF, MR, DM, JU, PA, SA, AM, SD, NB, MQ, SS implemented the project implementation and conducted study procedures. IR and SS performed and/or supervised the microbiological testing, including Urine Culture and antimicrobial resistance testing; SS supervised all laboratory procedures. LCM, AK, RK, and ACL conducted the data analysis. LCM, AHB, ACL had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. ACL drafted the first version of the manuscript with LVF. All authors have read, input, and approved the final manuscript.

Corresponding author

Correspondence to Anne CC Lee.

Ethics declarations

Ethics approval and consent to participate

The study protocol was approved by the institutional review boards of Johns Hopkins Bloomberg School of Public Health Institutional Review Board (Baltimore, Maryland), International Centre for Diarrhoeal Disease Research, Bangladesh Ethical Review Committee (iccdr,b) (Dhaka, Bangladesh), and Partners Human Research Committee (Boston, MA).

Participants were enrolled after providing verbal informed consent for the main RCT. Verbal consent was obtained because the majority of the prospective study population was illiterate at the initiation of the study (2012). Documentation of verbal informed consent was formally approved by all participating institutional review boards.

The study was explained to the study participants, questions answered, and the name of the study participant, date of consent, and name/signature of the study staff obtaining verbal consent were collected on a paper consent document. A paper copy of the consent form was provided to the study participant.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lee, A.C., Mullany, L.C., Koffi, A.K. et al. Urinary tract infections in pregnancy in a rural population of Bangladesh: population-based prevalence, risk factors, etiology, and antibiotic resistance. BMC Pregnancy Childbirth 20, 1 (2020).

Download citation


  • Urinary tract infection
  • Asymptomatic bacteriuria
  • Bangladesh
  • Pregnancy
  • Maternal morbidity
  • Risk factors
  • Antimicrobial resistance